{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:13:24Z","timestamp":1714349604601},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,28]]},"DOI":"10.7759\/cureus.59186","type":"journal-article","created":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T07:36:11Z","timestamp":1714289771000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Hypernatremia in a Newly Diagnosed Patient With Acute Myeloid Leukemia: Lessons for Nephrologists"],"prefix":"10.7759","author":[{"given":"Valerio","family":"Rasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Forest","family":"Riekhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon","family":"Ejiofor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krista","family":"Lentine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac547","article-title":"Changing the name of diabetes insipidus: a position statement of the working group for renaming diabetes insipidus","volume":"108","author":"Arima H","year":"2022","unstructured":"Arima H, Cheetham T, Christ-Crain M, et al.. Changing the name of diabetes insipidus: a position statement of the working group for renaming diabetes insipidus. J Clin Endocrinol Metab. 2022, 108:1-3. 10.1210\/clinem\/dgac547","journal-title":"J Clin Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13233","article-title":"New developments and concepts in the diagnosis and management of diabetes insipidus (AVP-deficiency and resistance)","volume":"35","author":"Angelousi A","year":"2023","unstructured":"Angelousi A, Alexandraki KI, Mytareli C, Grossman AB, Kaltsas G. New developments and concepts in the diagnosis and management of diabetes insipidus (AVP-deficiency and resistance). J Neuroendocrinol. 2023, 35:e13233. 10.1111\/jne.13233","journal-title":"J Neuroendocrinol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020791","article-title":"Central diabetes insipidus and autoimmunity: relationship between the occurrence of antibodies to arginine vasopressin-secreting cells and clinical, immunological, and radiological features in a large cohort of patients with central diabetes insipidus of known and unknown etiology","volume":"88","author":"Pivonello R","year":"2003","unstructured":"Pivonello R, De Bellis A, Faggiano A, et al.. Central diabetes insipidus and autoimmunity: relationship between the occurrence of antibodies to arginine vasopressin-secreting cells and clinical, immunological, and radiological features in a large cohort of patients with central diabetes insipidus of known and unknown etiology. J Clin Endocrinol Metab. 2003, 88:1629-36. 10.1210\/jc.2002-020791","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2019.01.005","article-title":"Acute myeloid leukemia with central diabetes insipidus","volume":"76","author":"Ladigan S","year":"2019","unstructured":"Ladigan S, Mika T, Figge A, May AM, Schmiegel W, Schroers R, Baraniskin A. Acute myeloid leukemia with central diabetes insipidus. Blood Cells Mol Dis. 2019, 76:45-52. 10.1016\/j.bcmd.2019.01.005","journal-title":"Blood Cells Mol Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8898671","article-title":"Concurrent central diabetes insipidus and acute myeloid leukemia","volume":"2021","author":"Pritzl SL","year":"2021","unstructured":"Pritzl SL, Matson DR, Juckett MB, Ciske DJ. Concurrent central diabetes insipidus and acute myeloid leukemia. Case Rep Hematol. 2021, 2021:10.1155\/2021\/8898671","journal-title":"Case Rep Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0103-2","article-title":"Diabetes insipidus","volume":"5","author":"Christ-Crain M","year":"2019","unstructured":"Christ-Crain M, Bichet DG, Fenske WK, Goldman MB, Rittig S, Verbalis JG, Verkman AS. Diabetes insipidus. Nat Rev Dis Primers. 2019, 5:54. 10.1038\/s41572-019-0103-2","journal-title":"Nat Rev Dis Primers"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13991","article-title":"Copeptin and its role in the diagnosis of diabetes insipidus and the syndrome of inappropriate antidiuresis","volume":"91","author":"Refardt J","year":"2019","unstructured":"Refardt J, Winzeler B, Christ-Crain M. Copeptin and its role in the diagnosis of diabetes insipidus and the syndrome of inappropriate antidiuresis. Clin Endocrinol (Oxf). 2019, 91:22-32. 10.1111\/cen.13991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1055\/a-2198-7207","article-title":"Desmopressin dose requirements in adults with congenital and acquired central diabetes insipidus","volume":"56","author":"Pedersen AN","year":"2024","unstructured":"Pedersen AN, Andreassen M, Rasmussen AK, Krogh J. Desmopressin dose requirements in adults with congenital and acquired central diabetes insipidus. Horm Metab Res. 2024, 56:206-13. 10.1055\/a-2198-7207","journal-title":"Horm Metab Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2020.101385","article-title":"Management of central diabetes insipidus","volume":"34","author":"Garrahy A","year":"2020","unstructured":"Garrahy A, Thompson CJ. Management of central diabetes insipidus. Best Pract Res Clin Endocrinol Metab. 2020, 34:101385. 10.1016\/j.beem.2020.101385","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-21-0153","article-title":"Central diabetes insipidus and partial anterior pituitary dysfunction in acute myeloid leukemia","volume":"2022","author":"Arya R","year":"2022","unstructured":"Arya R, Ahmad T, Dash S. Central diabetes insipidus and partial anterior pituitary dysfunction in acute myeloid leukemia. Endocrinol Diabetes Metab Case Rep. 2022, 2022:21-0153. 10.1530\/EDM-21-0153","journal-title":"Endocrinol Diabetes Metab Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/246489-a-case-of-hypernatremia-in-a-newly-diagnosed-patient-with-acute-myeloid-leukemia-lessons-for-nephrologists","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T07:36:15Z","timestamp":1714289775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/246489-a-case-of-hypernatremia-in-a-newly-diagnosed-patient-with-acute-myeloid-leukemia-lessons-for-nephrologists"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,28]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.59186","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,28]]}}}